NTLA ▼ -0.1% - Intellia Therapeutics, Inc.
$NTLA - Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
13-OCT-2026 07:30 AM ET
Share this post
More filings for $NTLA
NTLA ▼ -4.8% - Intellia Therapeutics, Inc.Oct 7, 2026NTLA ▼ -2.4% - Intellia Therapeutics, Inc.Oct 6, 2026NTLA ▲ +0.6% - Intellia Therapeutics, Inc.Oct 2, 2026NTLA ▲ +0.9% - Intellia Therapeutics, Inc.Oct 2, 2026NTLA ▲ +0.7% - Intellia Therapeutics, Inc.Sep 10, 2026NTLA ▲ +5.7% - Intellia Therapeutics, Inc.Sep 8, 2026
View full $NTLA filing history →💬 Comments
Loading comments…
Leave a comment